Company Overview and News
45 of 52 NASDAQ Index dividends were presumed "safer" because they showed positive one-year returns and free cash flow yields greater than dividend yields as of 6/7/17.
LRCX AMGN VOD VOD GILD CMCSA WDC STX PCAR KLAC HAS VODPF AMAT AVGO CSCO QCOM MXIM PAYX
The futures traded slightly higher Thursday morning as investors digested Wednesday’s huge rally, which basically rode on the back of the political situation in Italy cooling off some and Italian sovereign bond yields, which had skyrocketed, coming back to earth some.
H GLW MS.PRE MS.PRF QSII MS.PRG PCAR MS.PRA DSW MS.PRI BIIB GRUB MS.PRK BOX TRI MS
In one sense, Tuesday's market action was a risk parity investor's bad dream: both stocks and bonds saw price declines.
STT STT.PRC STT.PRE STT.PRD MS.PRE STT.PRG MS.PRF MS.PRG PCAR UTX MS.PRA CMI SPYR BRK.A SGLRF MS.PRI BK MS.PRK AAPL MSFT MS XSPY
Another Tesla (TSLA - Free Report) Autopilot executive has left the company for rival Waymo. According to media reports, Matthew Schwall is now a part of Alphabet (GOOGL - Free Report) company Waymo's safety team led by former National Highway Traffic Safety Administration (NHTSA) Deputy Administrator Ron Medford.
FOXF GOOGL GM.WS.A GM.WS.B GM.WS.C PCAR GM INTC GM.WSB
Auto companies’ increasing preference for sports utility vehicles (SUVs) and trucks are reshaping the industry. Even concerns over high interest rates and growing oil prices could not stop Americans from splurging on SUVs and pickup trucks. This has led to strong unit sales of SUVs, crossovers and pickup trucks. In the past week, a news regarding Ford Motor Company’s (F - Free Report) declining vehicle production in Mexico surfaced as the company planned to exit the sedan market of the United States.
AXL TM TYT PCAR TOYOF GM.WS.A GM.WS.B GM.WS.C 7203 GM GM.WSB AAP SUP
CVGI is seeing good volume and stronger margins on very healthy volumes of commercial trucks and construction equipment, with significant improvements in the GCA business.
CVGI PCAR CMI
DETROIT (Reuters) - North American orders for Class 8 semi-trucks jumped nearly 50 percent in April as trucking companies struggled to add capacity in a tight U.S. freight market, but the pace of orders cooled from highs seen in the first quarter, FTR, a company that tracks the industry, said on Thursday.
NAV NAV.PRD VOLVF PCAR VOLVY DDAIF VOLAF VLVLY
2018-06-11 - Asif
Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...
2018-06-11 - Asif
Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...
2018-06-11 - Asif
Overview Stemline Therapeutics was incorporated under the laws of the State of Delaware in August 2003. Stemline Therapeutics is a clinical stage biopharmaceutical company focused on discovering, acquiring, developing and potentially commercializing innovative oncology therapeutics that target difficult to treat cancers. The company's clinical pipeline includes: SL-401, SL-801, and SL-701. SL-401 pivotal data; plans for registration and potential commercialization: SL-401 has completed a pivotal trial in patients with blastic plasmacytoid dendritic cell neoplasm, or BPDCN, and has successfully met the primary endpoint of the trial. SL-401 is a targeted therapy directed to the interleukin-3 receptor-a, or CD123. SL-401 was granted breakthrough therapy designation, or BTD, by the U.S. Food and Drug Administration, or FDA, for the treatment of patients with BPDCN. Based on the trial results and other data, the company expect to complete submission of a rolling Biologics License...
Silicon Investor Message Boards
This table lists all message boards related to PCAR / PACCAR, Inc. on message board site Silicon Investor.
|ZIP ZipCar Car Sharing Service|
as of ET